News
Investors are betting that Lilly will maintain its momentum. Its share price has climbed by a third since the start of 2024; ...
A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...
Lilly Ledbetter’s journey began in 1979 at the Goodyear Tire & Rubber Co. plant in Gadsden. Her experience working there led ...
Patricia Clarkson shines as Lilly Ledbetter in Lilly, even when the movie feels like a rushed made-for-TV movie.
Emmy and Golden Globe-winning actress Patricia Clarkson joins Morning Joe to discuss starring as equal pay-activist Lilly ...
Sales are booming for Lilly's tirzepatide products, Mounjaro and Zepbound. The company's market share for incretin analogs now tops 50%. Notably, Lilly's market share is increasing while Novo ...
A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...
Following the sell-off, Lilly trades at a forward price-to-earnings (P/E) of 37 times 2025 analyst estimates, with a price-to ...
Eli Lilly and Company (NYSE: LLY) shares are trading lower Tuesday. The stock appears to be moving in reaction to an ...
1d
WISH-TV on MSNLilly breaks ground on $4.5 billion R&D facilityEli Lilly officials and Gov. Mike Braun break ground on the LEAP District's Lilly Medicine Foundry, a $4.5 billion project ...
Officials from the Indianapolis-based drugmaker said the Lilly Medicine Foundry will help streamline the process of ...
Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results